Not every patient who carries Clostridioides difficile ( C diff) gets sick, and distinguishing colonization from true ...
Jordan Feld, MD, MPH, discusses bepirovirsen's approval and how capsid assembly modulators and gene editing could lead to a true hepatitis B cure. It is the first therapy approved with a primary ...
Permanent standard time is the only option that ends biannual clock changes while keeping the body aligned with the sun, ...
Karolinska Institutet’s Antoine Créon, MD, explains how alert fatigue, workflow, and center-level variation may have limited ...
Naima T. Joseph, MD, MPH, discusses why measles immunity screening in pregnancy is debated and how vaccination and counseling ...
OneOncology's Larry Bilbrey outlines network-level contracting, data security, physician review of AI output, and clear ...
The FDA on Friday approved a subcutaneous (SC) induction regimen for risankizumab-rzaa (Skyrizi; AbbVie) in adults with moderately to severely active Crohn disease, giving patients the option to begin ...
Recognizing Typical Lesions, Locations, and Chronicity" takes up the question of how clinicians can recognize HS reliably. Dr ...
Nevena Vicic, MSc, discusses first real-world data showing mRNA-1283 protected adults 65 and older from COVID-19 hospitalization in 2025-2026.
Universal HCV testing, community-based prevention, and peer navigators can help curb a decade-long surge in new US hepatitis ...
The FDA approved talazoparib plus enzalutamide for HRR-mutated metastatic hormone-sensitive prostate cancer after TALAPRO-3 cut progression risk by 52%. In mHSPC, the cancer has spread outside the ...
As cancer treatments improve and patients are living longer, answering the question of who takes charge of care once active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results